This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovations of Helen Barr
Introduction
Helen Barr is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of biomedical research, particularly in the detection of infections caused by Pseudomonas aeruginosa. Her work has implications for improving patient outcomes and advancing medical diagnostics.
Latest Patents
Helen Barr holds a patent titled "Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof." This patent describes a method for determining the infection status of a subject by analyzing a sample of material obtained from them. The method involves measuring the levels of alkyl quinolones or their metabolites produced by Pseudomonas aeruginosa or related species in the sample. She has 1 patent to her name.
Career Highlights
Helen Barr is affiliated with the University of Nottingham, where she conducts her research and develops her innovative ideas. Her work has garnered attention for its potential to enhance diagnostic techniques in clinical settings.
Collaborations
Helen has collaborated with notable colleagues, including Miguel Camara and Paul Williams, to further her research and expand the impact of her findings.
Conclusion
Helen Barr's contributions to the field of infection diagnostics exemplify the importance of innovation in healthcare. Her patent and ongoing research continue to pave the way for advancements in medical technology.